在资源有限的环境中区分非结核性菌根性肺病与肺结核病:减少误导性抗结核治疗的实用模型
Wei Zhang1, Jun Chen1, Zhenhua Chen2
1Hunan Key Laboratory of Viral Hepatitis, Department of Infectious Diseases, Xiangya Hospital Central South University, Changsha 410008, China.
Healthcare (Basel, Switzerland)
|May 14, 2025
概括
区分非结核性菌根性肺病 (NTM-PD) 和肺结核病 (PTB) 是一个挑战. 一个使用临床预测因素的新模型,如性别,血和肺结构,有助于区分这些条件,特别是在资源有限的地区.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 诊断成像 诊断成像 诊断成像
背景情况:
- 区分非结核菌性肺病 (NTM-PD) 和肺结核病 (PTB) 很难,因为症状相似,导致在资源有限的环境中经常出现诊断错误.
- 准确的区分对于适当的治疗和防止滥用抗结核疗法至关重要.
研究的目的:
- 确定区分NTM-PD与PTB的关键临床预测因素.
- 开发和验证一种诊断模型,以区分NTM-PD和PTB.
主要方法:
- 追溯病例控制研究涉及210名患者 (105名NTM-PD,105名PTB) 通过菌根菌培养得到证实.
- 临床,实验室和放射学数据的比较.
- 多变量后勤回归和ROC曲线分析以确定预测因素并评估诊断模型.
主要成果:
- 对于NTM-PD的独立预测因素包括女性性别,血,支气管切除,肺/肺.
- 系统性症状 (发烧,夜间出汗,体重减轻) 更多地表明PTB.
- 开发的模型实现了91.4%的特异性和68.6%的灵敏度,AUC为0.871.1.
结论:
- 结合临床和放射学发现的诊断模型可以有效地区分NTM-PD和PTB.
- 该模型有助于在特定患者群体 (患有血和肺结构变化的女性) 中优先确定NTM-PD确认,并在系统性症状突出时保持PTB怀疑.
- 该方法有可能减少在资源有限的环境中等待培养结果的不适当的抗结核疗法.
相关概念视频
Pulmonary Tuberculosis IV
123
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
123
Pulmonary Tuberculosis III
270
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
270
Pulmonary Tuberculosis V
157
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
157
Pulmonary Tuberculosis I
210
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
210
Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pneumonia III: Complications and Assessment
127
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
127


